The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Richard Berman Biography and Net Worth

Director of Cryoport

Mr. Berman, age 78, became a member of our board of directors in January 2015 and serves as Lead Director, Chairman of the Audit Committee and member of the Compensation Committee and Nomination and Governance Committee of our board of directors. Mr. Berman’s business career spans over 35 years of venture capital, senior management and merger & acquisitions experience. Mr. Berman has served as a director and/or officer of over a dozen public and private companies. From 2006 to 2011, he was Chairman of National Investment Managers, a company with $12 billion in pension administration assets. Mr. Berman is currently a director of four publicly traded companies: Cryoport Inc., Comsovereign Holding Corp., BioVie, Inc. and Cuentas Inc. Over the last decade he has served on the board of 5 companies that have reached over one billion in market capitalization – Cryoport, Advaxis, EXIDE, Internet Commerce Corporation, and Ontrak (Catasys). Previously, Mr. Berman worked at Goldman Sachs; was Senior Vice President of Bankers Trust Company, where he started the M&A and Leveraged Buyout Departments; created the largest battery company in the world in the 1980’s by merging Prestolite, General Battery and Exide to form Exide Technologies (XIDE); helped to create what is now Soho (NYC) by developing five buildings; and advised on over $4 billion of M&A transactions. He is a past Director of the Stern School of Business of NYU where he obtained his BS and MBA. He also has U.S. and foreign law degrees from Boston College and The Hague Academy of International Law, respectively. Mr. Berman’s financial and business expertise, including his background in biotechnology, international management and banking, and his extensive experience as a director in the public company context makes him well-qualified to serve as a member of the board of directors.

What is Richard J. Berman's net worth?: The estimated net worth of Richard J. Berman is at least $657,000.00 as of May 15th, 2024. Mr. Berman owns 100,000 shares of Cryoport stock worth more than $657,000 as of November 21st. This net worth estimate does not reflect any other investments that Mr. Berman may own. Learn More about Richard J. Berman's net worth.
How do I contact Richard J. Berman?: The corporate mailing address for Mr. Berman and other Cryoport executives is 112 Westwood Place Suite 350, Brentwood TN, 37027. Cryoport can also be reached via phone at (949) 470-2300 and via email at [email protected]. Learn More on Richard J. Berman's contact information.
Has Richard J. Berman been buying or selling shares of Cryoport?: Richard J. Berman has not been actively trading shares of Cryoport over the course of the past ninety days. Most recently, Richard J. Berman sold 8,105 shares of the business's stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $13.41, for a transaction totalling $108,688.05. Following the completion of the sale, the director now directly owns 100,000 shares of the company's stock, valued at $1,341,000. Learn More on Richard J. Berman's trading history.
Who are Cryoport's active insiders?: Cryoport's insider roster includes Richard Berman (Director), Daniel Hancock (Director), Mark Sawicki (Insider), Jerrell Shelton (CEO), Robert Stefanovich (CFO), and Edward Zecchini (Director). Learn More on Cryoport's active insiders.
Are insiders buying or selling shares of Cryoport?: During the last twelve months, insiders at the sold shares 19 times. They sold a total of 144,455 shares worth more than $1,730,633.69. The most recent insider tranaction occured on November, 19th when CEO Jerrell Shelton sold 50,000 shares worth more than $339,000.00. Insiders at Cryoport own 10.1% of the company. Learn More about insider trades at Cryoport.
Information on this page was last updated on 11/19/2024.

Richard J. Berman Insider Trading History at Cryoport

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/15/2024	Sell	8,105	$13.41	$108,688.05	100,000
5/11/2023	Sell	7,203	$21.51	$154,936.53	100,000
12/1/2022	Sell	7,250	$19.63	$142,317.50
8/16/2022	Sell	2,708	$43.05	$116,579.40	107,203
9/15/2021	Sell	25,000	$64.00	$1,600,000.00
11/11/2020	Sell	20,000	$55.55	$1,111,000.00	8,300
11/19/2019	Sell	5,000	$14.66	$73,300.00
11/15/2019	Sell	10,000	$15.27	$152,700.00
3/15/2019	Sell	30,000	$11.84	$355,200.00
11/15/2018	Sell	30,000	$10.06	$301,800.00
9/6/2018	Sell	10,000	$14.00	$140,000.00
8/15/2018	Sell	20,000	$12.81	$256,200.00

Richard J. Berman Buying and Selling Activity at Cryoport

Cryoport Company Overview

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Today's Range

Now: $6.57

$6.48

$6.94

50 Day Range

MA: $7.57

$6.57

$8.73

2 Week Range

Now: $6.57

$5.32

$20.10

Volume

567,933 shs

Average Volume

567,216 shs

Market Capitalization

$324.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.63

Financial Prophecy

From Porter & Company | Ad